Intraoperative Dexamethasone and Its Effect on Hyperglycemia

Phase 4

Withdrawn

• Conditions: Diabetes Mellitus
• Interventions: Drug: Dexamethasone; Other: No dexamethasone

• Registration Number: NCT03646916
• Lead Sponsor: Ascension Health

Brief Summary

To study the effect of intra-operative dexamethasone on the management of post-operative blood sugar in diabetic patients.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2018-08-23
• Study First Submitted QC: 2018-08-23
• Study First Posted: 2018-08-24
• Study Start: 2020-09-15
• Primary Completion: 2020-12-31
• Study Completion: 2020-12-31
• Status Verified: 2021-01
• Last Update Submitted: 2021-01-19
• Last Update Posted: 2021-01-22

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• documented history of Type I or Type II Diabetes Mellitus
• scheduled for surgery that requires patients to be admitted for at least 24 hours post-surgery

Exclusion Criteria

• Patients on steroid therapy
• Pregnant women
• Patients at low risk for nausea/vomiting

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Dexamethasone	Dexamethasone	-
Dexamethasone	No dexamethasone	-

Primary Outcome Measures

Name	Time	Method
Post-operative blood sugar	24 hour Post surgery

Trial Locations

Locations (1)

Genesys Regional Medical Center; 🇺🇸 Grand Blanc, Michigan, United States